|
LO-1
|
will be able to evaluate the pharmacokinetic factors altering drug-induced effects during pregnancy |
|
LO-2
|
will be able to evaluate the pharmacokinetic factors altering drug-induced effects during lactation. |
|
LO-3
|
evaluate the pharmacokinetic factors altering drug-induced effects in pediatric patients. |
|
LO-4
|
discuss possible risks of drug use during pregnancy. |